Beruflich Dokumente
Kultur Dokumente
Countries therefore need to build on the local capacity emerging in the form of local companies and small and medium-size enterprises.
Who would run such a clearinghouse? And who would cover the costs? The questions remain open. One possible solution to the financing issue would be to have member countries contribute a share of revenues from patents.
115
Creating a sound system for risk assessment requires several strategic interventions by governments
Clearinghouse activities to facilitate access by poor farmers to patented research results are already being undertaken by CAMBIA IP Resource (Australia), which is funded by the Rockefeller Foundation. The institution aims to enhance the ability of public sector institutions and small and medium-size enterprises to develop biotechnology for improving crops worldwide (see http://www.cambiaip.org). Another initiative, the Global Knowledge Centre on Crop Biotechnology, part of the International Service for the Acquisition of Agri-biotech Applications (ISAAA) family, is committed to sharing information on crop biotechnology with as many people as possible (http://www.isaaa.org/kc). The CGIAR system itself could become the virtual host for an Internet-based exchange system. Efforts also need to be made to create the biotechnology equivalent to the open source movement in the software industry, so that new scientific discoveries worldwide can be assessed and applied to food insecurity and poverty in a timely manner. This would entail: Providing public access to open source research results, under the condition that those who use the freely accessible material will in return make their research results accessible to others. Conducting research on the business case underlying the open source movement.
116
Establishing a clear policy framework with coherent guidelines outlining where responsibility for the introduction of innovations in biotechnology begins and ends. Developing policy that guarantees the systematic and comprehensive testing of all new technology with inputs not just from the natural sciences, assessing the health risks, but also from research and regulatory bodies able to map out potential socio-economic risks. This broad review is necessary to ensure that the ludicrous and heartbreaking does not arisethat more people die from hunger while more food is being produced, because they cannot afford the food. Ensuring that risk assessment has a built-in system of checks and balances to safeguard the independence of test resultsso that the potential risk of new products is not assessed by those wanting to release the product on the market.
of the technology to the neediest. Countries also need to ensure that poor farmers have access to extension services, local markets, productive resources (land, water, credit), and infrastructure. Given the already strained budgets of many African countries, strategic public-private partnerships should be encouraged. Such partnerships have had excellent successes in telecommunications (mobile telephony), in micro-finance and education, and in the construction of dams, roads, ports, and railways. In the medium term there is a need to promote local seed companies to ensure a smooth transfer of the technology to the neediest
Conclusion
Biotechnology offers rich opportunities to increase agricultural productivity and address current food shortages in Africa. It accelerates plant and animal breeding efforts. It offers solutions to previously intractable problems. But it is no panacea. African countries need to develop appropriate national policies and identify key national priorities for biotechnology, bearing in mind the potential biological risks and the needs of poor people who rely on agriculture for their livelihoods. And the international community needs to loosen the arrangements for access to proprietary technologyenabling developing countries to provide poor farmers with improved seeds while protecting them from inappropriate restrictions on propagating their crops. Open debate is essential. Governments should involve diverse stakeholders in the development of national biotechnology policies, strategies, and plans. And they should encourage full and candid discussions on biotechnology, aimed at determining how best to address problems while building achievements. Biotechnology policy should take into account national development policies, private sector interests, market opportunities, and mechanisms and links for the diffusion of technology. The biggest risk for Africa would be to do nothing, allowing the biotechnology revolution to pass the continent by. If that happens, Africa will miss opportunities for reducing food insecurity and child malnutrition and see the agricultural productivity gap with industrial countries widen. The result could be what Ismail Serageldin (1999), former chairperson of the CGIAR, calls scientific apartheid, with cutting-edge science oriented exclusively towards industrial countries and large-scale farming.
118
119
120